v3.25.1
Share-Based Compensation Expense (Tables)
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option award activity
The Company grants stock options to certain employees that will vest over a period of one to four years. A summary of stock option award activity for the three months ended March 31, 2025 was as follows:
Options
Shares
Weighted Average
Exercise Price		Weighted Average Remaining Contractual Term
Outstanding at December 31, 2024
488,385 $9.34 7.5
Granted— — 
Exercised— — 
Cancelled or forfeited— — 
Outstanding at March 31, 2025
488,385 $9.34 7.3
Exercisable at March 31, 2025
192,985 $17.86 4.5
A summary of stock option award activity for the three months ended March 31, 2024 was as follows:
Options
Shares
Weighted Average
Exercise Price		Weighted Average Remaining Contractual Term
Outstanding at December 31, 2023
193,156 $17.89 5.8
Granted— — 
Exercised— — 
Cancelled or forfeited— — 
Outstanding at March 31, 2024
193,156 $17.89 5.5
Exercisable at March 31, 2024
191,931 $17.58 5.5
Schedule of fair value of restricted stock awards Restricted stock units activity during the three months ended March 31, 2025 was as follows:
Number of
Shares		Weighted Average Grant Date Fair Value Per Share
Non-vested, at December 31, 2024
2,233,816 $4.60 
Granted— — 
Vested(28,732)5.92 
Cancelled or forfeited(153,945)3.13 
Non-vested, at March 31, 2025
2,051,139 $4.69 
Restricted stock units activity during the three months ended March 31, 2024 was as follows:
Number of
Shares		Weighted Average Grant Date Fair Value Per Share
Non-vested, at December 31, 2023
1,102,095 $7.74 
Granted— — 
Vested(5,060)9.36 
Cancelled or forfeited(813)6.64 
Non-vested, at March 31, 2024
1,096,222 $7.74